Literature DB >> 15259854

Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.

Subrata Mallick1, Ashok Sahu, Kaushik Pal.   

Abstract

The oral bioavailability of nalidixic acid (NA) is low due to its poor solubility and slow dissolution. Solid dispersions of NA containing varying concentrations of polyvinylpyrrolidone (PVP), beta-cyclodextrin (BCD) and sodium starch glycolate (SSG) were prepared by solvent evaporation technique in an attempt to improve dissolution rate of NA. Physical characterization of NA, physical mixtures (PM) and solid dispersions were investigated by a variety of analytical methods including scanning electron microscopy (SEM), infrared (IR) spectroscopy and powder X-ray diffraction (XRD). SEM was useful in the verification of possible nalidixic acid inclusion in the dispersion system by studying its surface and shape characteristics of different samples. IR analysis demonstrated no strong interaction between the drug and the carrier exists in the solid dispersions. The degree of crystallinity of nalidixic acid decreased and also differed with the dispersion systems of different carriers. Disolution studies indicated that the dissolution rate and percent dissolution efficiency (DE) were significantly increased in the solid dispersions compared with drug alone. The relative potency of the carriers to enhance the dissolution rate of nalidixic acid was in the order: BCD > PVP > SSG. The dissolution rate of the drug in the solid dispersions was faster when the ration of the drug to carrier was smaller. F-test suggests that first order model may be used for explaining the kinetics of drug release from all the solid dispersion systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259854

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  3 in total

Review 1.  Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.

Authors:  Dariusz Boczar; Katarzyna Michalska
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

2.  Optimization of In - vitro Permeation Pattern of Ketorolac Tromethamine Transdermal Patches.

Authors:  Pintu Kumar De; Subrata Mallick; Biswajit Mukherjee; Sagar Sengupta; Satyanarayan Pattnaik; Subrata Chakraborty
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

Review 3.  Recent Bio-Advances in Metal-Organic Frameworks.

Authors:  Isobel Tibbetts; George E Kostakis
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.